Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma

被引：2
|
作者：
Zhang, Xuan [1 ]
Bi, Chengfeng [1 ]
Lu, Ting [2 ]
Yue, Ting [3 ]
Zhang, Weiwei [1 ]
Zhang, Xiaoyan [4 ]
Cheng, Wang [1 ]
Tian, Tian [1 ]
Lunning, Matthew A. [1 ]
Vose, Julie M. [1 ]
Pelletier, Jerry [5 ]
Porco, John A., Jr. [6 ]
Tao, Jianguo [7 ]
Fu, Kai [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] China Yixueke Xueyuan Hemopathy Hosp, Tianjin, Peoples R China
[5] McGill Univ, Montreal, PQ, Canada
[6] Boston Univ, Boston, MA 02215 USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine
    Daniel C. Moreira
    Sujatha Venkataraman
    Apurva Subramanian
    John Desisto
    Ilango Balakrishnan
    Eric Prince
    Angela Pierce
    Andrea Griesinger
    Adam Green
    Charles G. Eberhardt
    Nicholas K. Foreman
    Rajeev Vibhakar
    Journal of Neuro-Oncology, 2020, 147 : 531 - 545
  • [42] Mnt modulates Myc-driven lymphomagenesis
    Campbell, Kirsteen J.
    Vandenberg, Cassandra J.
    Anstee, Natasha S.
    Hurlin, Peter J.
    Cory, Suzanne
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (12): : 2117 - 2126
  • [43] A Vulnerable Side to MYC-Driven Cancers
    不详
    CANCER DISCOVERY, 2015, 5 (11) : 1116 - 1116
  • [44] Targeting PHF5A for the treatment of glioblastoma and other Myc-driven cancers
    Mhyre, Andrew J.
    Turnbaugh, Shanon
    Morris, Shelli M.
    Xin, Hu
    Paddison, Patrick J.
    Ferrer, Marc
    Olson, James M.
    CANCER RESEARCH, 2017, 77
  • [45] Targeting the transcription co-activator TAZ inhibits MYC-driven medulloblastoma
    Xue, Yingchao
    Ying, Mingyao
    CANCER RESEARCH, 2017, 77
  • [46] Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine
    Moreira, Daniel C.
    Venkataraman, Sujatha
    Subramanian, Apurva
    Desisto, John
    Balakrishnan, Ilango
    Prince, Eric
    Pierce, Angela
    Griesinger, Andrea
    Green, Adam
    Eberhardt, Charles G.
    Foreman, Nicholas K.
    Vibhakar, Rajeev
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (03) : 531 - 545
  • [47] Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma
    Donati, Giulio
    Nicoli, Paola
    Verrecchia, Alessandro
    Vallelonga, Veronica
    Croci, Ottavio
    Rodighiero, Simona
    Audano, Matteo
    Cassina, Laura
    Ghsein, Aya
    Binelli, Giorgio
    Boletta, Alessandra
    Mitro, Nico
    Amati, Bruno
    EMBO MOLECULAR MEDICINE, 2023, 15 (06)
  • [48] Investigating the role of PD-L1 expression in MYC-driven lymphoma
    Brugger, M.
    Gruen, J.
    Steidle, S.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 71 - +
  • [49] Combination therapy targeting ribosome biogenesis and mRNA translation provides a novel and potent therapeutic approach to treat MYC-driven malignancy
    Devlin, Jennifer R.
    Rebello, Richard J.
    Hannan, Katherine M.
    Cullinane, Carleen
    Drygin, Denis
    Risbridger, Gail P.
    Furic, Luc
    Hannan, Ross D.
    Pearson, Richard B.
    CANCER RESEARCH, 2016, 76
  • [50] Mnt modulates Myc-driven lymphomagenesis
    Kirsteen J Campbell
    Cassandra J Vandenberg
    Natasha S Anstee
    Peter J Hurlin
    Suzanne Cory
    Cell Death & Differentiation, 2017, 24 : 2117 - 2126
12345